Viewing nowVivaCo 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

MFDS item code 201400435 · Approved 2014.01.29 · Insurance code 640006760
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used to manage dyslipidemia, including hypercholesterolemia and mixed hyperlipidemia. It serves as an adjunct when diet and exercise alone are insufficient, particularly effective in patients with primary hypercholesterolemia and heterozygous familial hypercholesterolemia. Additionally, it helps reduce the incidence of cardiovascular diseases such as strokes and myocardial infarctions in patients with cardiovascular risk factors. It can be used in pediatric patients who meet specific criteria in conjunction with diet. Thus, this medication effectively lowers cholesterol levels to improve vascular health and delay the progression of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in patients with allergies to specific ingredients. Patients with poor liver function or liver diseases should be cautious as it may worsen liver function. Patients with muscle diseases or problems may face a higher risk of muscle damage while taking this medication. Coadministration with certain drugs such as cyclosporine increases the risk of side effects, and it should be avoided. Patients with severe kidney impairment are contraindicated from using this medication. Pregnant or breastfeeding women, and those planning to become pregnant, should not take this medication, and women of childbearing potential must use appropriate contraception. The 40 mg dosage is contraindicated in patients at high risk of muscle-related issues and should be used cautiously in those with moderate to severe kidney impairment, hypothyroidism, or family history thereof. This medication contains lactose, so it should not be used in patients with genetic issues such as lactose intolerance. Patients with excessive alcohol intake or a history of liver disease require regular liver function tests and should take this medication only after cause-specific treatment for hypothyroidism or nephrotic syndrome. If muscle pain, weakness, or cramps occur, notify a doctor immediately and discontinue use if symptoms are severe. It is safer to discontinue use in acute severe conditions, sepsis, or after major surgeries. This medication can rarely cause severe muscle weakness or ophthalmoplegia; if symptoms occur, it should be discontinued immediately. The risk of muscle disease may increase when used with certain other medications, so caution is required when co-administering. Kidney function tests are needed for high-dose use, and dosages may need to be adjusted for Asian patients due to higher drug concentrations. In pediatric and adolescent cases, there may be influences on growth and development requiring caution. Rare side effects, such as interstitial lung disease, severe liver damage, and severe skin reactions, may occur while taking this medication, so if they arise, it should be immediately discontinued and healthcare professionals consulted. This medication can interact with other drugs, so it is crucial to inform providers of any medications currently being taken, especially those that pose a risk of muscle damage. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned, appropriate contraception must be used. In the case of overdose, there is no specific antidote, so treatment should be given according to symptoms, and liver function and muscle enzyme tests must be performed to monitor the condition. Symptoms such as dizziness may occur when driving or operating machinery, so caution is advised.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, fatigue
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container as it may be sensitive to air and humidity. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness over time.
Yellow round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.